RTP biotech banks federal grant to treat age-related disorders
Research Triangle Park-based ZenBio has banked a new federal grant aimed at the treatment of age-related disorders.
The $220,000, one-year grant was awarded to ZenBio on March 15 by the National Institute on Aging, part of the National Institutes of Health. Through the Phase I Small Business Innovation Research grant, ZenBio will develop technology to use exosomes, or vesicles, secreted from stem cells to tre at such age-related disorders as chronic tendon injuries.
“We know that there are…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Jennifer Henderson Source Type: news
More News: Biotechnology | Grants | Health Management | National Institutes of Health (NIH) | Small Businesses | Stem Cell Therapy | Stem Cells